These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1685787)

  • 1. [Effect of neuroleptic treatment on positive and negative symptoms of schizophrenia and the results of the dexamethasone test].
    Rybakowski J; Linka M
    Psychiatr Pol; 1991; 25(1):1-6. PubMed ID: 1685787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
    Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
    Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.
    Mauri MC; Vita A; Giobbio GM; Ferrara A; Dieci M; Bitetto A; Altamura AC
    Int Clin Psychopharmacol; 1994; 9(1):3-7. PubMed ID: 8195579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
    Wik G; Wiesel FA; Eneroth P; Sedvall G; Aström G
    Acta Psychiatr Scand; 1986 Aug; 74(2):161-7. PubMed ID: 2877544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia.
    Taylor SF; Tandon R; Shipley JE; Eiser AS
    Biol Psychiatry; 1991 Nov; 30(9):904-12. PubMed ID: 1684117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms and schizophrenic relapses: the effect of four neuroleptic drugs.
    Mauri MC; Bitetto A; Fabiano L; Laini V; Steinhilber C; Fornier M; Rafique F
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):43-54. PubMed ID: 10368855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of antidepressants in the treatment of negative symptoms of schizophrenia].
    Palomba A; Lodovighi MA; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S36-40. PubMed ID: 26776391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects.
    Selten JP; Gernaat HB; Nolen WA; Wiersma D; van den Bosch RJ
    Am J Psychiatry; 1998 Mar; 155(3):350-4. PubMed ID: 9501744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative symptoms during neuroleptic treatment.
    Kramer MS
    Biol Psychiatry; 1991 Mar; 29(6):620-1. PubMed ID: 1675891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.